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Understanding phenotype–genotype correlations in retinal degeneration is a major challenge. Mutations in
CRB1 lead to a spectrum of autosomal recessive retinal dystrophies with variable phenotypes suggesting the
influence of modifying factors. To establish the contribution of the genetic background to phenotypic variability
associated with theCrb1rd8/rd8mutation, we compared the retinal pathology ofCrb1rd8/rd8/J inbred mice with that
of twoCrb1rd8/rd8 linesbackcrossedwithC57BL/6JOlaHsdmice.Topicalendoscopic fundal imagingandscanning
laser ophthalmoscopy fundus images of all threeCrb1rd8/rd8 lines showed a significant increase in the number of
inferior retinal lesions that was strikingly variable between the lines. Optical coherence tomography, semithin,
ultrastructural morphology and assessment of inflammatory and vascular marker by immunohistochemistry
and quantitative reverse transcriptase-polymerase chain reaction revealed that the lesions were associated
with photoreceptor death, Mu¨ller and microglia activation and telangiectasia-like vascular remodelling—features
that were stable in the inbred, variable in the second, but virtually absent in the third Crb1rd8/rd8 line, even at 12
months of age. This suggests that the Crb1rd8/rd8 mutation is necessary, but not sufficient for the development
of these degenerative features. By whole-genome SNP analysis of the genotype–phenotype correlation, a candi-
date region on chromosome 15 was identified. This may carry one or more genetic modifiers for the manifestation
of the retinal pathology associated with mutations inCrb1. This study also provides insight into the nature of the
retinal vascular lesions that likely represent a clinical correlate for the formation of retinal telangiectasia or Coats-
like vasculopathy in patients withCRB1 mutations that are thought to depend on such genetic modifiers.
INTRODUCTION
Understanding the genotype–phenotype correlation in retinal
degenerations remains a major challenge even for monogenetic
diseases. Although the causality of many primary mutations has
been convincingly established, the clinical manifestation of even
identical mutations can be highly variable. This may be due to
additional genetic polymorphisms in the same gene (allelic
heterogeneity) or in additional genes (genetic modifiers) as
well as environmental factors. The combination of all these
factors in a patient may influence age of onset, progression and
severity of disease as well as the development of particular
phenotypic features associated with a primary mutation (1,2).
One example of mutations in a gene that lead to a highly vari-
able spectrum of clinical phenotypes is the CRB1 gene (OMIM
#604210).They typicallycausea spectrum ofautosomal recessive
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(ar) rod-cone dystrophies that ranges from retinitis pigmentosa
(RP12) (3) to Lebers congenital amaurosis (LCA) (4,5). Both
arRP- and arLCA-patients that carry CRB1 mutations may
show additional specific features in fundus images such as pres-
ervation of para-arteriolar retinal pigment epithelium and retinal
telangiectasia with exudates (also called Coats-like vasculopa-
thy) (3–7). So far no genotype–phenotype correlation with
mutations in CRB1 for any of these clinical features has been
established, except that CRB1 null-mutations may be over-
represented in LCA cases (5–7). This wide range of clinical
characteristics in patients with CRB1 mutations suggests that
additional genetic and environmental modifiers influence the
development of the disease (5,6,8).
CRB1 is a member of the highly conserved CRB protein
family that in mammals comprises two additional members,
CRB2 and CRB3 (9,10). While expression of CRB1 is restricted
to the retina and the brain (3), CRB2 and CRB3 show a wider
range of tissue expression (11,12).
In the retina, CRB1 is part of the CRB/Crb complex, which is
localized at the outer limiting membrane (OLM) where it sits just
apically to the adhesion junctions (AJ) that connect photorecep-
tors with each other and with Mu¨ller glia cells (10). The CRB/
Crb complex and Crb1 in particular seem to regulate the polarity
of these cells and appear crucial for maintaining stratification of
the retina (10,13–16).
Two mouse models with different mutant Crb1 alleles exist
(13,16). The Crb1rd8 allele carries a single base pair deletion
of a cytosine in exon 9 (Crb1. 3841delC) that causes a frame
shift and premature stop codon resulting in a predicted truncated
protein that only consists of the N-terminal extracellular domain
(17). The Crb1 null allele instead leads to complete ablation of
Crb1 protein expression by genetic targeting of the Crb1 gene
sequence containing the upstream promoter, exon 1 with the
start codon and part of intron 1 (13). Consistent with the auto-
somal recessive trait of arRP and arLCA, only homozygous
mice for each of the two alleles show degenerative changes in
the retina (13,16). Crb1rd8/rd8 mice exhibited a prominent focal
inferior retinal degeneration characterized by the formation of
local retinal folds, pseudorosettes, photoreceptor loss and retinal
thinning with earliest signs of degeneration at 2 weeks of age
(16). Crb12/2 mice also develop an inferior retinal degener-
ation, but their degenerative features are less prominent and
frequent, comprising of small localized photoreceptor displace-
ments, half rosettes and loss of OLM in affected areas and are
only consistently seen from 3 months of age onwards (13,15,16).
This variability in age of onset and severity of the retinal degener-
ation between lines carrying different alleles suggests that either
the allelic heterogeneity contributes to the phenotypic differences
or that, similar to humans, the phenotype in mice is highly variable
and may be influenced by genetic and environmental factors.
Many other inbred knockout mouse and ES cell lines also
carry the Crb1rd8/rd8 mutation in a homozygous state (18). This
mutation therefore has likely confounded the phenotypic de-
scription and subsequent conclusions drawn from many mouse
models for retinal disease. One recent example is an early
onset retinal degeneration seen in Ccl22/2/Cx3cr12/2 double
knockout mice that turned out to be dependent on the homozy-
gous Crb1rd8/rd8 allele instead on a previously proposed syner-
gistic effect of the combined knockout of both chemokines
(19). To prevent such misinterpretation due to the unnoticed
presence of the Crb1rd8/rd8 mutation in the future, we here aim
to evaluate the range and variability of phenotypic features asso-
ciated with this mutation. Therefore, we compared the retinal
pathology of three homozygous Crb1rd8/rd8 mouse lines that
were of different genetic origin but were raised in an identical en-
vironment. We describe primary consequences of theCrb1rd8/rd8
mutation, identify secondary phenotypic features that did not
manifest in all Crb1rd8/rd8 lines and identify a candidate region
on chromosome 15 that may carry additional genetic factors
that determine the severity of the retinal pathology caused by
mutations in Crb1.
RESULTS
To establish the degree of phenotypic variability in homozygous
Crb1rd8/rd8 mice, we analysed three different Crb1rd8/rd8 mouse
lines at 2 months of age using autofluorescent scanning laser
ophthalmoscopy (AF-SLO; Fig. 1). All Crb1rd8/rd8 lines
showed significantly higher number of autofluorescent lesions
in the inferior retina than wild-type mice (Fig. 1). However, a
striking variability in the manifestation of this phenotype was
observed between lines. While the genetically independent
Crb1rd8/rd8/J inbred line showed high and stable number of char-
acteristic large irregular lesions (Fig. 1A–C), significantly fewer
lesions were observed in the two closely related lines [Fig. 1M,
C57BL/6 Crb1rd8/rd8 (1) and (2)]. Autofluorescent lesions in
C57BL/6 Crb1rd8/rd8 (1) mice were small, weak, reduced in
number and located more inferiorly (Fig. 1D–F), while typical
large lesions were seen in C57BL/6/Crb1rd8/rd8 (2) mice, but
with a high degree of variability (Fig. 1G–I and M).
Large irregular inferior lesions that correspond to
localized displacement of photoreceptors are not
observed in all homozygous Crb1rd8/rd8 mice
Topical endoscopic fundal imaging (TEFI), AF-SLO, optical
coherence tomography (OCT) and semithin histology revealed
that this pathology was mainly confined to the inferior retina
of Crb1rd8/rd8 mice (Fig. 2). White/opaque and autofluorescent
fundus lesions correlated well with the position of lesions in
OCT images at the outer plexiform layer (OPL) and in the
outer nuclear layer (ONL) (Fig. 2A–C). Corresponding rosette
formation (Fig. 2A and B, white arrows) and drop out and disrup-
tion of photoreceptor columns (Fig. 2A–C, arrow heads) were
observed in sagittal semithin sections of prominently affected
Crb1rd8/rd8 mice. However, not all Crb1rd8/rd8 mice showed
these inferior lesions by TEFI or AF-SLO. In particular, in the
C57BL/6/Crb1rd8/rd8 (1) mice only small inferior lesions were
visible (Fig. 2D) that were very difficult to identify in OCT and
semithin sections (Fig. 2D) since these appeared to be very
similar to those from wild-type mice (Fig. 2E).
The Crb1rd8/rd8 mutation leads to reduced Crb1 mRNA
levels and absence of the CRB1 protein at the OLM
To further understand whether the Crb1rd8 allele, possibly by
altered expression of the predicted truncated CRB1 protein
(16), contributes to the phenotypic variability in different
strains and whether expression of Crb2 may be altered in a
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compensatory way, we quantified Crb1 and Crb2 transcript
levels relative to wild type in weakly and severely affected
Crb1rd8/rd8 mice (Fig. 3). We also evaluated whether the
genetic background of different inbred mouse strains influences
the expression level of Crb1 (Supplementary Material, Fig. S1).
Crb1 transcripts were significantly reduced to 20% of wild type
in all Crb1rd8/rd8 mice, independent of the severity of their pheno-
types (Fig. 3A). No significant changes in Crb2 transcript levels
were observed, although subtle effects cannot be excluded
(Fig. 3B). AlthoughCrb1 transcript levels were significantly influ-
enced by different genetic backgrounds, the influence of the homo-
zygous Crb1rd8/rd8 mutation on Crb1 transcript levels was always
much more pronounced (Supplementary Material, Fig. S1). Con-
sistent with these data, immunohistochemistry using a C-terminal
antibody for Crb1 revealed a weak specific signal across the whole
superior and inferior OLM in wild-type retina (OLM; Fig. 3C,
white arrow head), but not in any retina from Crb1rd8/rd8 mice
(Fig. 3D–F).
The lack of Crb1 leads to a variable reduction of number
of adhesions junctions at the OLM across the whole retina
To better understand how the loss of the evenly distributed CRB1
protein at the OLM might lead to a preferential degeneration in
the inferior retina and to see whether allCrb1rd8/rd8 homozygous
mice are similarly affected, we evaluated the integrity of the
OLM in the three differentially affected Crb1rd8/rd8 lines (Fig. 4).
Confocal evaluation on semithin sections across the whole retina
suggested that the OLM ofC57BL/6 Crb1rd8/rd8 (1) mice is macro-
scopically similar to that of wild-type mice (white arrow heads;
Fig. 4D versus E and I versus J). Also the tight junction protein
ZO-1 is evenly distributed along the whole OLM in all Crb1rd8/rd8
and wild-type mice (Fig. 4K–O and Ki–Oi). ZO-1 labelling only
became disrupted in the inferior retina if photoreceptor columns
were disorganized (red arrow heads, Fig. 4F–J), photoreceptor
nuclei dropped out of the ONL (red arrow heads, Fig. 4F–J) and
localized Mu¨ller glia became activated (Fig. 4K–M). All these fea-
tures were barely detectable in C57BL/6 Crb1rd8/rd8 (1) mice
(Fig. 4N and Ni, red arrowhead) and difficult to distinguish from
observations in wild-type mice (Fig. 4E and J and O and Oi).
Quantitative ultrastructural analyses revealed a variable reduc-
tion of adhesions junctions at the OLM from 16+1 AJ’s (range:
14–18) per 10 mm in wild-type mice to 12+3 per 10 mm (range:
7–14) in the superior and inferior retina of Crb1rd8/rd8 mice
(Fig. 4V). This reduction was not consistently observed in all
homozygous animals from both C57BL/6 Crb1rd8/rd8 (1 and 2)
lines. Also the expansion of the glial component at the OLM
seems similar at the inferior and superior OLM within each line,
but different between them (Fig. 4P, Q, S and T, red arrows).
Despite these line specific differences, both AJ reduction and
glial expansion seem to be primary consequences of the loss of
Crb1 that contributes to an even weakening of the OLM across
the superior and inferior retina.
Dying photoreceptors and associated local Mu¨ller and
microglia activation in the inferior retina were not
detected in weakly affected Crb1rd8/rd8 mice
The prominent degenerative changes in the inferior retina of
some Crb1rd8/rd8 mice lead us to further investigate an
Figure 1. Variable manifestation of the inferior retinal degeneration in different Crb1rd8/rd8 mouse lines at 2 months of age. Qualitative and quantitative in vivo phe-
notyping by AF-SLO of threeCrb1rd8/rd8 mouse lines andC57BL/6JCrb1+/+ control mice revealed the variable manifestation of large irregular lesions in the inferior
retina. Three representative AF-SLO fundus images for each of the Crb1rd8/rd8 lines are shown (A–C, Crb1rd8/rd8/J; D–F: C57BL/6 Crb1rd8/rd8 (1); G–I: C57BL/6
Crb1rd8/rd8 (2); J–L: C57BL/6J Crb1+/+). M: quantification of the number of lesions per fundus image differed significantly in variance (Bartlett’s test for equal
variances: P , 0.0001) and in number of lesions between Crb1rd8/rd8 mouse lines. Black lines indicate significant differences with P , 0.0001 using a one-way
ANOVA with Tukey’s multiple comparison test.
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association between photoreceptor death and Mu¨ller and micro-
glia activation (Fig. 5). Prominent loss of DAPI positive signal
on retinal flat mounts (Fig. 5A, B, Aii and Bii) and TUNEL
+
photoreceptor nuclei in sections (Fig. 5E) are consistent with
the darker labelling of photoreceptor nuclei (denser chromatin,
pyknotic cell nuclei) and inner segments observed at the base
of the whorls in semithin histology (e.g. Fig. 2A and C) and all
together indicated loss of photoreceptors at the ONL in inbred
Crb1rd8/rd8/J and C57BL/6 Crb1rd8/rd8 (2) mice. Without excep-
tion, these areas were closely associated with localized activa-
tion of microglia (Fig. 5Aiii and Biii) and Mu¨ller glia cell
(Fig. 5Aiv, BiV, E and F). However, no significant differences
in expression of chemokine (Ccl2, Ccr2, Cx3cl1 and Cx3cr1)
or microglia activation marker (iNos, Arg1 or TGFb) were
detected in retinas of different Crb1rd8/rd8 lines relative to wild
type supporting a localized response of microglia cells to these
degenerative events (Supplementary Material, Fig. S2). In all
these assessments, C57BL/6 Crb1rd8/rd8 (1) animals appeared
similar to wild-type mice with the exception of the rare appear-
ance of subtle aneurysm-like changes at the OPL (Fig. 5C, Ci – iV
and G). Three-dimensional (3D) reconstruction of large inferior
lesions revealed how activated Mu¨ller and microglia cells sur-
roundseveral photoreceptor columns at the OPL (Fig. 5I) andcon-
tribute to the formation of gliotic scars at the OLM (Fig. 5J). These
processes separate photoreceptor nuclei that have lost their
orderly arrangement within the ONL from still normally packed
and healthy photoreceptors in their close vicinity (Fig. 5K and L).
Localized severe loss of photoreceptors and closely
associated glial activation lead to telangiectasia-like
retinal vascular remodelling
The development of additional degenerative features during pro-
gression of the degeneration in different Crb1rd8/rd8 lines was
Figure 2. Retinal pathology of differentCrb1rd8/rd8 mouse lines illustrated by corresponding TEFI, AF-SLO fundus images and sagittal OCT and semithin sections at
2 months of age. (A–D) Example images of the different modalities including superior and inferior images from homozygous Crb1rd8/rd8 mice from the respective
lines. (A)Crb1rd8/rd8/J, (B, C)C57BL/6/Crb1rd8/rd8 (2), (D)C57BL/6/Crb1rd8/rd8 (1) and (E):C57BL/6Jwild-type mice (Crb1+/+). White arrow heads indicate lesions
affecting the structure of the ONL and the integrity of the OLM. White arrows indicate rosette formation observed in mice with severe manifestations of the phenotype.
These lesions are preferentially located in the inferior retina and correspond well with autofluorescent lesions in AF-SLO fundus images and with white/opaque lesions
in the fundus images obtained by TEFI. INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OLM, outer limiting membrane. Scale bar for
semithin images: 50 mm.
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assessed by AF-SLO and OCT imaging of animals of 12 months
of age and by evaluating retinal sections and flat mount prepara-
tions for aberrant vascular features using lectin B4 and CD31
labelling (Fig. 6). Mice from all lines showed at 12 months
very similar inferior retinal phenotypes as at 2 months of age
(Fig. 6 versus Fig. 1). The inbred Crb1rd8/rd8/J and the C57BL/
6 Crb1rd8/rd8 (2) lines showed again the prominent irregular
lesions in the inferior retina (Fig. 6A and B, red arrows), while
mice from the C57BL/6 Crb1rd8/rd8 (1) line still only revealed
very few small or even no inferior lesions (Fig. 6C, red arrow).
However, all Crb1rd8/rd8 lines showed a variable, but significant
increase in additional distinct autofluorescent spots across the
whole fundus indicating an accumulation of subretinal micro-
glia/macrophages in all lines compared with age-matched wild-
type mice (Fig. 6Ai–Di and E) (19). As early as 2 months, local
microglia (Fig. 6F) and Mu¨ller glial activation (Fig. 6G) inside
the large inferior retinal lesions were closely associated with
aneurysm-like vascular structures derived from deep retinal
capillaries (Fig. 6H) and with even larger vessels that extend
through holes in the ONL towards the RPE (Fig. 6I, arrow).
Such vessels were also seen at 12 months in severely affected
Crb1rd8/rd8 mice, but then extend from a strongly remodelled
vascular bed (Fig. 6J–L). These vessels do not break through
Bruch’s membrane according to our previous analysis of this
type of lesion (20). In contrast, C57BL/6 Crb1rd8/rd8 (1) mice
at 2 and 12 months of age did not show prominent vascular re-
modelling or microglia activation apart from a rare manifest-
ation of a few small aneurysms at the OPL (Fig. 5Ci), but
rather showed the three-layered vasculature typical of wild-type
mice (Fig. 6M).
Genetic loci on chromosome 15 may modify the
Crb1 rd8/rd8 phenotype
Despite the phenotypic stability of theCrb1rd8/rd8/J line, and the
common ancestry of the C57BL/6 Crb1rd8/rd8 lines (1) and (2),
there is a significant variation in the observed phenotype. We
reasoned therefore that a modifying gene or genes may have
Figure 3. TheCrb1rd8/rd8 mutation leads to reducedCrb1mRNA levels and the absence of the Crb1 protein at the OLM. mRNA expression analysis forCrb1 (A) and
Crb2 (B) by quantitative real-time RT-PCR and protein localization of Crb1 by immunohistochemistry (C–F) in retinas of wild-type (Crb1+/+) and homozygous
Crb1rd8/rd8 mice from the different lines at 8 weeks of age. (A) Quantitative real-time PCR detecting the exon 8 to mutant exon 9 boundary of Crb1 revealed
similar reduction of mutant Crb1 transcripts in all homozygous Crb1rd8/rd8 mice compared with wild type. Asterisks indicate a statistically significant difference
at P, 0.001 using one-way ANOVA with Tukey’s multiple comparison test. (B) No significant compensatory increase of Crb2 mRNA levels in either of the
Crb1rd8/rd8 lines (P ¼ 0.1693; one-way ANOVA with Tukey’s multiple comparison test). (C–F) Immunohistochemistry for Crb1 on sagittal retinal sections
shows a specific signal (red) for Crb1 at the level of the OLM (white arrow head) in the wild type (C), which was not detected in all other homozygous Crb1rd8/rd8
mouse lines (D–F). ONL, outer nuclear layer. Scale bar: 25 mm.
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been segregated between the lines. To test this, we first deter-
mined whether the different mouse lines carry any known
mutant alleles commonly found in inbred mouse strains (21)
that may be responsible for the modifying effect on the pheno-
type. We screened the mutant Pde6brd1 (c.1041C. A) allele
(22), two mutant alleles in the Gnat2 gene, Gnat2 (c.518A.G)
Figure 4. Assessment of OLM integrity and associated Mu¨ller glia activation in the superior and inferior retina of different Crb1rd8/rd8 mouse lines. Corresponding
confocal bright field images of the superior (A–E) and inferior (F–J) OLM (white arrow heads) in retinas of animals from respective lines. Scale bar: 20 mm. (K–O)
Corresponding images of the inferior retina obtained by immunohistochemistry for glial fibrillary acidic protein (GFAP, white, activated Mu¨ller glia and astrocytes),
the tight junction protein ZO-1 (green) and 4′,6-diamidino-2-phenylindole (DAPI, blue, nuclei) on sagittal retinal cryo-sections. Scale bar: 50 mm. (Ki–Oi) Magnified
views of the inferior disruptedOLM. Scale bar: 25 mm. Red arrow heads indicate predominant disruptionof the OLM in areas of the inferior retina where photoreceptor
disruption in the ONL is associated with localized Mu¨ller cell activation (white, GFAP+ processes of Mu¨ller glia cells). (P–U) Assessment of integrity of the OLM by
TEM. Representative TEM images with electron dense adhesions plaques (white arrow heads) and Mu¨ller glia processes (red arrows) from the superior and inferior
central retina ofCrb1rd8/rd8/Jmice,C57BL/6Crb1rd8/rd8 (line 1) and wild-type mice. Scale bar: 5 mm. (V) Quantification of number of electron dense AJ normalized to
the assessed distance of OLM and expressed as number of densities per 10 mm. Different colours and shapes represent the origin of individual wild-type orCrb1rd8/rd8
mice (black square:C57BL/6Jcontrols, yellow circle:C57BL/6JCrb1rd8/rd8 (1), green square:C57BL/6JCrb1rd8/rd8 (2) and open diamond:Crb1rd8/rd8/J). Overall, the
number of AJ per 10 mm shows a similar range of variable reduction in the superior and inferior retina ofCrb1rd8/rd8 mice compared with wild-type mice, although this
feature was not consistent in all Crb1 deficient mice.
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(23) andGnat2Cpfl3 (c.598G.A) (24), and the polymorphism in
theRpe65gene,RPE65Met450Leu [Rpe65 (c.1348C.A)], that has
been previously shown to be a genetic modifier for retinal degen-
eration (25). None of the mutations were identified in any of the
Crb1rd8/rd8 lines studied (Table 1) and therefore cannot explain
the observed phenotypic differences. All tested Crb1rd8/rd8 lines
were also homozygous for the RPE65Met450 allele indicating
that they all carry the allele common for the C57BL/6 genetic
background at this genomic position and thus do not differ in
this respect either (Table 1).
To provide further insight into a potential genetic basis for the
phenotypic variability, we decided to perform DNA SNP screen
analysis for animals from the different lines. The SNP data con-
firmed the inbred status of the Crb1rd8/rd8/J line for which we
Figure 5. Localized Mu¨ller and microglia activation occurs predominantly in the inferior retina and is associated with dying photoreceptors and vascular changes.
(A–D) Overlay of projection images of confocal z-stacks of 30–40 mm height located around the outer plexiform layer (OPL) of the central inferior retina of respective
Crb1rd8/rd8 mouse lines and wild-type controls at 2 months of age. For orientation, the deep retinal vascular plexus was labelled by Isolectin B4 (red, Ai, Bi, Ci, Di) and
the photoreceptor nuclei of the ONL by DAPI (blue, Aii, Bii, Cii, Dii). Microglia and Mu¨ller glia activation in the inner retina was assessed by Iba1 (green, Aiii, Biii,
Ciii, Diii) and GFAP (white, Aiv, Biv, Civ, Div) labelling. Scale bar: 75 mm. (E–H) Photoreceptor death in the retina was assessed qualitatively by TUNEL
+ labelling
(red) on superior to inferior oriented sagittal retinal sections and co-labelled with GFAP (white) for Mu¨ller cell activation. Images taken from the inferior central retina
are shown. Localized GFAP activation was closely associated with TUNEL+ (red) photoreceptor nuclei (blue). Scale bar: 50 mm. (I–L) 3D reconstruction using
Imaris software showing lectinB4
+ endothelial cells (red), Iba1+ microglia (green), DAPI-labelled photoreceptor nuclei in the ONL photoreceptor (blue) and
GFAP+ Mu¨ller cells (white). (I) View at the OPL towards the ONL. (J) Pronounced gliotic scar located at the outer surface of the ONL facing the subretinal
space. (J–I) Scale bar: 20 mm. 3D rotated side views of a single inferior lesion with (K) and without (L) representation of the ONL. Columns of photoreceptor
nuclei that are elevated from the ONL (K) are surrounded by activated GFAP+Mu¨ller cell processes and Iba1+microglia (K, L) suggesting a localized glial response
around these abnormally arranged photoreceptors. At the retinal ganglion cell layer, GFAP also labels astrocytes next to Mu¨ller cell processes. (K, L) Scale bar:
200 mm.
134 Human Molecular Genetics, 2015, Vol. 24, No. 1
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/24/1/128/2901056 by U
niversity Library user on 03 April 2019
observed a higher proportion of C3H (or identical) SNPs to be
present than in the two other C57BL/6 Crb1rd8/rd8 lines (data
not shown) suggesting that there are distinct genetic differences
between the inbred Crb1rd8/rd8/J line and the two C57BL/6
Crb1rd8/rd8 lines (1) and (2) that are of common ancestry.
Based on this common ancestry, and the distinct phenotypic
Figure 6. Assessment of retinal degeneration at 12 months of age and vascular remodelling at 2 and 12 months of age. (A–D) AF-SLO image focussed on the inner
retina of 12-month-old mice from the respectiveCrb1rd8/rd8 lines shows a similar degree of inferior retinal lesion as at 2 months of age indicating limited progression of
the degeneration with age. (Ai–Di) Corresponding AF-SLO images to (A)–(D), but focussed on the outer retina that revealed distinct autofluorescent spots suggestive
for subretinal macrophages. (E) Quantification of subretinal autofluorescent spots revealed a significant increase in number of subretinal macrophages in different
Crb1rd8/rd8 lines compared with age-matched wild-type mice. Corresponding confocal projection image of Iba1 (F), GFAP (G) and isolectinB4 (H) stained
retinal flat mounts at 2 months of age reveal that inside the irregular inferior retinal lesion (white arrow heads) vascular remodelling in the deep retinal capillaries
occurs in close associated with Mu¨ller and microglia activation. (I) Retinal sections even at 2 months of age sometimes show retinal vessels that grow through the
ONL towards the RPE. (J–M) 3D reconstruction of a lectinB4 labelled retinal vasculature of a Crb1rd8/rd8/Jmouse at 12 months of age. (J) View from the subretinal
space towards the retina revealed holes in the ONL and a retinal vessels growing through. Two-side views of the same vascular lesion represented with microglia
(green) and ONL nuclei (blue) (K) or without these features (L). They also illustrate the pronounced vascular remodelling of the retinal vasculature from which
the vessel extends. White arrows indicate retina-derived vessel that also grow through the RPE (Supplementary Material, movie S1). (M) Retinal vasculature with
microglia (green) and ONL (blue) of an age-matched wild-type mouse shows the normal three-layer architecture of the vascular bed (Supplementary Material,
movie S2).
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differences shown byC57BL/6 Crb1rd8/rd8 line (1) andC57BL/6
Crb1rd8/rd8 line (2), we decided to generate preliminary data
to help identify regions in the genome that may contain modify-
ing factors. We therefore performed an ‘analysis of extremes’
using DNA SNP screen data from animals that are from either
of the two related C57BL/6 Crb1rd8/rd8 lines (1) and (2), but
show the most divergent (extremes) of the AF-lesion phenotype.
Statistical analysis of this dataset identified a significant association
betweenthegenotypeonaregionofchromosome15andthepheno-
type (Table 2). As shown in Figure 7, there is a large region on
chromosome 15 where mice with low AF-lesion count are homo-
zygous for one allele (consistent with aC57BL/6 derived allele),
whereas mice with a high AF-lesion number are either heterozy-
gous or homozygous for alternative SNPs. These data suggest
that this region on chromosome 15 may carry one or several
genetic modifiers that determine the manifestation of the pheno-
type associated with the Crb1rd8/rd8 mutation.
DISCUSSION
In this study, we present data illustrating the wide range of vari-
able retinal pathologies associated with the Crb1rd8/rd8 muta-
tion and present initial genetic data from SNP screen analyses
that suggest the existence of genetic modifiers on chromosome
15 that modulate the manifestation of theCrb1rd8/rd8phenotype
in mice. These findings indicate that this mutation alone is
necessary, but not sufficient for the manifestation of the inferior
retinal degeneration and specific associated features, which
were only observed in two of the three evaluated homozygous
Crb1rd8/rd8 lines. This study also highlights how pronounced
the influence of small genetic background differences can be
on the manifestation of this retinal degeneration and presents
initial data for a candidate region that may carry the underlying
genetic modifier(s). This is an important issue since this muta-
tion has been found in many mouse strains across the world
(18). The present study clarifies primary and secondary con-
founding effects of the Crb1rd8/rd8 mutation on retinal pathology
in mice. Thereby, we aim to raise awareness for the variability of
the confounding effects that depend on the genetic context and
provide a reference for the evaluation of the current literature
in the retinal field and in future experimental studies involving
these mice.
Nonsense-mediated decay may act as a primary
mechanism of the rd8 allele resulting in loss of Crb1 protein
and weakening of the OLM across the whole retina
In addition our data may provide new insight into the primary
mechanism of action of the Crb1rd8/rd8 mutation. The observed
reduction of mutant Crb1 transcripts may indicate that nonsense-
mediated decay (NMD) occurs. NMD is a mechanism that results
in the degradation of mRNA transcripts that carry premature stop
codons and serves as a quality control to prevent the expression of
deleterious mutant proteins (26,27). However, this observation
does not exclude the possibility that a truncated mutant protein
is expressed from the remaining 20% of Crb1 transcripts and
may still contribute to the effect of the Crb1rd8/rd8 mutation by a
gain of function as previously considered (14,16).
Consistent with such a null or hypomorphic effect of the rd8
allele, our data also confirm that the Crb1 protein is lost at the
OLM in all lines, resulting in an evenly distributed but variable
Table 1. Genotyping of several mutant alleles common in inbred mouse strains did not explain the modifying effect observed in the different Crb1rd8/rd8
homozygous lines
Candidate alleles Crb1rd8/rd8/J C57BL/6 Crb1rd8/rd8(1) C57BL/6 Crb1rd8/rd8(2) C57BL/6J Balb/c 129 S2/Sv
Crb1rd8 (c.3481delC)∗ 100% (10/10) 100% (7/7) 100% (15/15) 0% (0/4) 0% (0/4) 0% (0/4)
Pde6brd1 (c.1041C.A) 0% (0/10) 0% (0/7) 0% (0/15) 0% (0/4) 0% (0/4) 0% (0/4)
Gnat2 (c.518A.G) 0% (0/8) 0% (0/5) 0% (0/15) 0% (0/3) 0% (0/3) 0% (0/3)
Gnat2Cpfl3 (c.598G.A) 0% (0/10) 0% (0/7) 0% (0/15) 0% (0/4) 0% (0/4) 0% (0/4)
RPE65Leu450/Leu450 or
RPE65Met450/Met450 (c.1348C.A)
100% (10/10)
RPE65Met450
100% (7/7)
RPE65Met450
100% (15/15)
RPE65Met450
100% (4/4)
RPE65Met450
100% (4/4)
RPE65Leu450
100% (4/4)
RPE65Leu450
Percentage and absolute number of the genotyping result for the respective mutant and modifying allele. These results were obtained by DNA sequencing of individual
animals from the three homozygous Crb1rd8/rd8/J, C57BL/6 Crb1rd8/rd8(1) and C57BL/6 Crb1rd8/rd8(2) mouse lines (n ¼ 10 each) and from wild-type animals from
inbred lines with different genetic backgrounds (C57BL/6J, Balb/c and 129 S2/Sv) that served as controls (n ¼ 4 each). In addition to the represented animals in this
table all animals used in this study were genotyped for the Crb1rd8 allele.
Table 2. Statistical analysis of the genotyping results from both C57/Bl6
Crb1rd8/rd8 lines 1 and 2 with either high (n ¼ 11) or low (n ¼ 11) number of
autofluorescent fundus lesions
SNP Position in bp/Chr. 15 P-value
rs13459176 3279130 1.01E204
CEL-15_8331158 8474279 1.03E204
CEL-15_9687257 9788004 6.22E204
rs13482431 11311464 6.22E204
rs3711814 13219494 6.22E204
CEL-15_15482356 15577251 9.27E205
rs13482455 16731203 9.27E205
rs13482469 20942406 9.27E205
rs13482477 22519205 9.27E205
rs13482485 25450871 9.27E205
rs13482504 30322280 2.91E204
rs13482509 32042169 2.91E204
rs6188239 34331233 2.91E204
rs3695416 38484397 2.91E204
CEL-15_43206205 43188178 2.91E204
rs13482543 43870893 2.91E204
rs13482558 47166660 2.91E204
rs13482571 49998375 2.91E204
Listed are all informative SNPs that showed significant differences between the
two groups based on a Pearson’s x2 test indicating the genomic region on
chromosome 15 that is associated with the incidence of the AF-lesions
phenotype.
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reduction of AJ at the OLM across the whole retina. However,
this reduction was not fully established in each individual
mouse, caused either by a sampling bias due to the analysis of
sections or an intrinsic variability of the phenotype caused by
line specific differences. The latter interpretation is consistent
with discrepancies in the number of AJ reported for Crb1rd8/rd8
andCrb12/2mice in the literature (15,16) and further supported
by the line differences in Mu¨ller cell process expansion at the
OLM between the Crb1rd8/rd8/J and the C57BL/6 Crb1rd8/rd8
lines observed at the ultrastructural level. Both effects correlate
well in their localization, with the absence of the Crb1 protein
confirming its involvement in OLM maintenance across the
whole retina as previously suggested (13).
Additional genetic modifier(s) located on chromosome
15 determine the severity and additional phenotypic
features in Crb1rd8/rd8 mice
Prominent differences in the manifestation of the retinal degen-
eration in different homozygous Crb1rd8/rd8 lines and the
miss-match of the localization of the degenerative phenotype
with the primary OLM defect suggest that the inferior features
are secondary consequences dependent on additional factors.
However, the presence of the homozygous Crb1rd8/rd8 mutation
seems necessary since heterozygous or wild-type littermates did
not show any phenotypic features when evaluated during estab-
lishment of the two Crb1rd8/rd8 lines (20).
Because of the inferior nature of the degeneration, light was
considered to be a good candidate for such an additional initiat-
ing factor for this type of retinal degeneration. Yet, this hypoth-
esis was recently excluded by the observation that both,Crb12/2
and Crb1rd8/rd8 mice raised in complete darkness from birth
show a similar degree of inferior retinal degeneration as those
raised under normal light conditions (15,20). Since all three
Crb1rd8/rd8 mouse lines studied here were raised in the same
environment, but still showed prominent differences in their
phenotype, predominantly genetic factors may define these add-
itional phenotypic features. This also confirms a previous report,
in which 19% of homozygous Crb1rd8/rd8 mice on a C57BL/6
background did not exhibit retinal spots in fundus images impli-
cating the strong modulatory role of the genetic background (16).
Our study strengthens this argument by revealing the genetic and
phenotypic stability of the Crb1rd8/rd8/J inbred and the C57BL/6
Crb1rd8/rd8 line (1) over multiple generations. Furthermore, our
observation that the two closely related C57BL/6 Crb1rd8/rd8
lines (lines 1 and 2), still differ significantly in their phenotype
suggests that a few genetic factors or even a single factor may
be responsible for the modifying effects in the different lines.
By using an ‘analysis of extremes’ on the SNP data obtained
from animals with the most divergent phenotypes from the two
related C57BL/6 Crb1rd8/rd8 lines (1) and (2), we identified a
large region on chromosome 15 that is significantly associated
with the phenotype and thus may carry such genetic modifiers.
While animals with few retinal lesions are homozygous for one
allele, consistent with a C57BL/6 allele, animals with a many
lesions are either heterozygous or homozygous for an alternative
allele. Therefore, the modifying factor(s) on chromosome 15 may
act either as recessive suppressor(s) or as dominant enhancer(s)
for the manifestation of the Crb1rd8/rd8 phenotype. However,
our data do not allow us to conclude with certainty about the
origin of the modifying factor(s) from either of the genetic back-
grounds since it could be the result of a spontaneous mutation in
any of the alleles. To answer these questions and gain mechanistic
insight into the function of these additional genetic factors, a more
Figure 7. SNP genotype across a large region on chromosome 15 that shows homozygosity in mice with low number of AF-lesions (n ¼ 11) (dark grey), while those
with high number of AF-lesions are either heterozygous (grey) or homozygous (white) for an alternate base.
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extensive mapping or QTL project would be required to confirm
our initial results and narrow down the genomic region on
chromosome 15 which may then result in the identification of
the genetic modifying factor(s) for the Crb1rd8/rd8 phenotype.
Secondary vascular remodelling in a subset of Crb1rd8/rd8
lines resembles retinal telangiectasia seen in patients
with Crb1 mutations
Based on our observations, the modifying factors may be mech-
anistically involved in photoreceptor survival, e.g. by affecting
additional genes in the Crb1 pathway, or alter processes that
define the threshold of Mu¨ller glia or microglia responses.
A general innate immune activation during disease progression
was indicated by the increased accumulation of subretinal
macrophages inallCrb1rd8/rd8miceduring later stages.Additional
modulating factors that further alter such inflammatory or gliotic
responses may lead to an even more permissive inflammatory and
pro-angiogenic environment in the retina and may result in vascu-
lar remodelling and additional degenerative features. However,
the question of why the inferior retina is preferentially affected
by these processes remains unresolved. Nevertheless, it is of par-
ticular interest that the localized aneurysms- and telangiectasia-
like vascular lesions in Crb1rd8/rd8 mice were clinically similar
to retinal telangiectasia or Coats-like vasculopathy in patients
with CRB1 mutations and that the manifestation of these lesions
in humans also seems to be dependent on genetic modifying
factors (6,7). Since the vascular remodelling occurred in close
association with Mu¨ller and microglia activation it is tempting
to speculate that activated glial cells drive this pathological
process. Recent reports support such a role for tissue macrophages
and Mu¨ller glia cells in regulating angiogenesis by the expression
of pro-angiogenic factors such as VEGFA or by guiding endothe-
lial cell growth and fusion during developmental and pathological
angiogenesis in the retina (28–30).Our datanow present a starting
point for the design of future genetic studies that aim to identify
these modifying factors. It not only has provided evidence that
the number of lesions in the inferior retina of Crb1rd8/rd8 mice
may be useful as a quantitative trait for genetic studies (31) but
also presents a candidate region on chromosome 15 that—if con-
firmed—needs to be narrowed down in order to identify the
modifying factor(s). These factors may not only be of particular
relevance to establish genotype–phenotype correlations for
retinal degenerations caused by mutation in CRB1, but may
also help to identify novel pathways that could be targeted thera-
peutically for the modulation of inflammatory neurovascular
processes contributing to the progression of inherited and
multifactorial retinal degenerations.
MATERIALS AND METHODS
Animals
A Crb1rd8/rd8/J inbred line derived from the Jackson laboratory
(#003392; referred to as Crb1rd8/rd8/J) was compared with two
genetically related homozygous Crb1rd8/rd8 lines obtained
from a backcross experiment with C57BL/6J Ola Hsd mice, re-
ferred to as C57BL/6J Crb1rd8/rd8 (1) and C57BL/6J Crb1rd8/rd8
(2), respectively (20). Genotyping for the Crb1rd8 allele and
other mutant alleles was performed as described previously
using polymerase chain reaction (PCR) amplification with flank-
ing primers and subsequent sequencing (20). The genomic PCR
primer and the respective mutant alleles are shown in Table 3.
Mice were anaesthetized by intraperitoneal injection of mede-
tomidine hydrochloride (1 mg/kg body weight; Domitor; Pfizer
Animal Health, New York, NY, USA) and ketamine (60 mg/kg
body weight). Pupils were dilated with 1% tropicamide. Animal
experiments were performed in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research and the UK Home Office licence (PPL 70/1279).
Housing
To minimize environmental differences, all lines were housed
under the same 12 h/12 h dark/light cycling. During light, animals
were exposed to an illuminance of 38+28 lux (mean+SD; range
7–100 lux), when lids, food and water bottles were in place.
Outside the cages 200+ 136 lux (range 50– 500 lux) were
measured (32).
AF-SLO, OCT and TEFI imaging for in vivo phenotyping
As described previously, autofluorescent fundus images and OCT
images were obtained using the HRA2 scanning laser ophthalmo-
scope with a 558 angle lens and the SpectralisTM HRA+OCT with
a 308 angle lens, respectively (Heidelberg Engineering, Heidel-
berg, Germany) (20). The optic disc was positioned at the centre
and 30 frames for AF-SLO or 50 frames for OCT images were
acquired. Colour fundus images were taken by TEFI using Visco-
tears (Novartis Pharmaceuticals, UK) as a coupling agent with a
5 cm endoscope of 3 mm outer diameter (1218AA; Karl Storz,
Tuttlingen, Germany) connected to a Nikon D300 s camera
(33). All images were processed with Adobe Photoshop CS2
(Adobe Systems Incorporated, San Jose, CA, USA).
Quantification of autofluorescent AF-SLO images
The severity of the phenotype (all autofluorescent signals) and
the number of subretinal macrophages (distinct small spots) were
determined by counting respective lesions on images focussed on
the superficial retina for pathology or on the outer retina for
subretinal macrophages.
Table 3. Primer pairs used for PCR amplification on genomic DNA and
subsequent sequencing for genotyping of mutant or modifying alleles
Allele Primer sequences References
Crb1rd8 (c.3481delC) Forw: gcacaatagagattggaggc
Rev: tgtctacatccacctcacag
(20)
Gnat2Cpfl3 (c.598G.A) Forw: catcgagaccaagttttctg
Rev: accatgtcgtaggcactgag
(24)
Gnat2 (c.518A.G) Forw: accgatgccaccttcttttt
Rev: tgctgtgagacctgagatgc
(23)
Pde6brd1 (c.1041C.A) Forw: cacacccccggctgatcactg
Rev: ctgaaagttgaacatttcatc
(22)
RPE65Leu450/Leu450 or
RPE65Met450/Met450
(c.1348C.A)
Forw: tgacaaggtaataaagcatc
Rev: attaccatcatcttcttcca
(25)
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Histopathology and ultrastructural assessment
of adhesion plaques
Semithin and ultrastructural histology of superior to inferior
oriented sagittal sections of the retina were performed as previ-
ously described (19,32). After cardiac perfusion with 1% paraf-
ormaldehyde (PFA), eyes were post-fixed in 3% glutaraldehyde
and 1% PFA in 0.08 M sodium cacodylate–HCl (pH 7.4) and pro-
cessed for embedding in araldite resin (Agar Scientific Limited,
Essex, UK). Semithin (0.7 mm) and ultrathin sections (70 nm)
were stained accordingly and imaged by bright field microscopy
(Oberserver.Z1 Axio, Carl Zeiss Microimaging, Jena, Germany)
or transmissionelectronmicroscopy(TEM) witha JEOL1010 con-
nected to a Gatan Orius CCD camera. Calibrated images were
imported into Image J for quantification (34). Electron dense adhe-
sion plaques were counted in five linearly stitched TEM images at
×1000 magnification and normalized to the distance counted.
Immunohistochemistry and 3D reconstruction
Tissue was fixed and dissected in 4% PFA, cryoprotected with
20% sucrose and embedded in OCT (Tissue Tek, Sakura
Finetek, Thatcham, UK). Eighteen micrometres of retinal sec-
tions or flat mounts were blocked with 1% BSA (Sigma-Aldrich,
Steinheim, Germany)/5% goat serum (AbD Serotec, Kidlington,
UK) including 3% (flat mounts) or 0.3% (sections) Triton X-100
for permeabilization followed by overnight incubation at 48C
with respective primary and secondary antibodies (Table 4).
The ApopTagw In Situ Apoptosis Detection kit was used for
TUNEL labelling according to manufacturer’s instruction
(Millipore, Watford, UK). After counterstaining with Hoechst
33342 (Dako, Cambridgeshire, UK) and mounting in fluorescent
mounting medium (Dako), images were taken by confocal
microscopy (Leica DM5500 Q, Leica Microsystems, Wetzlar,
Germany). High-resolution Z-stack images were used for 3D
reconstruction with Imaris (Bitplane, Zurich, Switzerland).
Genomic SNP screening and ‘analysis of extremes’
SNP screening was performed by the Mammalian Genetics Unit
at the MRC Harwell, Oxfordshire, UK. Twenty microliters of
genomic DNA (50 ng/ml in TE) per animal were analysed on
an SNP array containing 1449 allele-specific probes from
across the genome distinguishing C57BL/6 and C3H alleles.
To assess whether the observed SNP variant between the two
groups and the two background strains was purely random, a
x2 test was applied. For comparison between the two groups, a
frequency tables were generated by grouping animals by the base
variants seen in each strain. A Pearson’sx2 test was then used to de-
termine whether the variant frequencies differed purely by random
or were significantly associated with the phenotype.
Quantitative reverse transcriptase-polymerase chain
reaction
Total RNA from retinas was extracted using the RNeasy Mini
Kit (Qiagen, Manchester, UK) followed by cDNA synthesis
with the QuantiTect Reverse Transcription kit (Qiagen). For
Real Time PCR analysis, 20 ml reactions were prepared in tripli-
cates containing the FastStart TaqMan Probe Master Mix (Roche,
West Sussex, UK) with 5 ml of template cDNA, 200 nM of each
primer and 100 nM of the corresponding FAM-labelled probe
(see Table 5). Assays were run in 96-well plates using an ABI
PRISMTM 7900HT FastReal Time PCR System (Applied Biosys-
tems, Paisley, UK) at default settings. Data were analysed using
the SDS 2.2.2 software (Applied Biosystems).
Table 4. Primary and secondary antibodies used in this study with respective working concentrations
Primary and secondary antibodies/reagent Company (product code/clone) Working dilution (final concentration)
Isolectin B4 (BSI-B4) Sigma (L2140) 1 : 200 (5 mg/ml)
Rabbit anti-Iba1 antibody WAKO (No. 019-19741) 1 : 500 (1 mg/ml)
Rat anti-GFAP Merck Chemicals (# 345860/2.2B10) 1 : 200 (2.5 mg/ml)
Rabbit anti-ZO-1 Abcam (Ab59720) 1 : 200 (0.5 mg/ml)
Rabbit anti-Crb1 Gift from Jan Wijnholds 1 : 200
goat anti-rabbit AlexaFluor 488 nm-conjugated highly cross adsorbed Life Technologies Ltd #A11034 1 : 500 (4 mg/ml)
Alexa Fluorw 488 goat anti-rat IgG (H+L) Life Technologies Ltd #A11006 1 : 500 (4 mg/ml)
Alexa Fluorw 546 goat anti-rabbit IgG (H+L) highly cross adsorbed Life Technologies Ltd #A11035 1 : 500 (4 mg/ml)
Alexa Fluorw 546 goat anti-rat IgG (H+L) Life Technologies Ltd #A11081 1 : 500 (4 mg/ml)
streptavidin, Alexa Fluor 633 conjugate Life Technologies Ltd #S21375 1 : 500 (2 mg/ml)
Table 5. Real-time PCR assays with corresponding primers and Roche
FAM-labelled universal probes
Assay Primer sequences Roche universal probe library
Ccl2 Forw: catccacgtgttggctca
Rev: gatcatcttgctggtgaatgagt
#62
Ccr2 Forw: acctgtaaatgccatgcaagt
Rev: tgtcttccatttcctttgatttg
#27
Crb1 Forw: caactcagcccatgtcctc
Rev: aaaacagcctttgcgataca
#32
Crb2 Forw: caggattctctggccagttc
Rev: caggcactgctacctccag
#34
Cx3cl1 Forw: ccgaattcctgcactcca
Rev: catgatttcgcatttcgtca
#66
Cx3cr1 Forw: ggagtctgcgtgagactgg
Rev: agcagatgggaagggaactt
#4
Nos2 Forw: ctttgccacggacgagac
Rev: tcattgtactctgagggctgac
#13
Arg1 Forw: gaatctgcatgggcaacc
Rev: gaatcctggtacatctgggaac
#2
Tgfb1 Forw: tcagacattcgggaagcagt
Rev: acgccaggaattgttgctat
#56
Actb Forw: aaggccaaccgtgaaaagat
Rev: gtcgtacgaccagaggcatac
#56
Assays were designed using the online Assay Design Centre (www.roche-app
lied-science.com).
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Statistical analysis
Statistical analyses were performed using GraphPad Prism 5
(GraphPad Software, Inc., La Jolla, CA, USA).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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